Application of trastuzumab emtansine in HER‐2–positive and KRAS/BRAF‐mutated colon cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Application of trastuzumab emtansine in HER‐2–positive and KRAS/BRAF‐mutated colon cancer cells

Published:2020-05-18 Issue:8 Volume:50 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Chung Yuan‐Chiang¹,Chiu Hsi‐Hsiung²,Wei Wan‐Chen¹³,Chang King‐Jen⁴,Chao Wei‐Ting³^ORCID

Affiliation:

1. Department of Surgery Cheng‐Ching General Hospital Taichung Taiwan

2. Department of Proctology Cheng‐Ching General Hospital Taichung Taiwan

3. Department of Life Science Tunghai University Taichung Taiwan

4. Department of Breast Surgery Cardinal Tien Hospital Taipei Taiwan

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13255

Reference35 articles.

1. Site-specific antibody drug conjugates for cancer therapy

2. Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates

3. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

4. Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer

5. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway;Frontiers in Pharmacology;2024-05-09

2. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

3. Translational research of new developments in targeted therapy of colorectal cancer;Pathology - Research and Practice;2023-12

4. Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers;Frontiers in Molecular Biosciences;2023-05-11

5. Case Report: A case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy;Frontiers in Oncology;2022-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3